Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | ERN1 | O75460 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | HBB | P68871 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.42 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 5/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL547777 | 1.00 | TDP1 (0.52) | TDP1LMNAKMT2AMEN1THRB | |
| SCHEMBL30402244 | 1.00 | TDP1 (0.52) | TDP1LMNAKMT2AMEN1THRB | |
| SCHEMBL652955 | 0.95 | LMNA (0.58) | TDP1LMNAKMT2AMEN1THRB | |
| SCHEMBL29364404 | 0.95 | LMNA (0.58) | TDP1LMNAKMT2AMEN1THRB | |
| Dimethylamine SCHEMBL10639493 | 0.85 | LMNA (0.48) | TDP1LMNAKMT2AMEN1THRB | |
| SCHEMBL5751119 | 0.84 | ALDH1A1 (0.45) | TDP1LMNAKMT2AMEN1THRB | |
| SCHEMBL6481048 | 0.84 | LMNA (0.54) | TDP1LMNAKMT2AMEN1THRB | |
| SCHEMBL10466277 | 0.84 | TRIM24 (0.50) | TDP1LMNAKMT2AMEN1THRB | |
| SCHEMBL6481045 | 0.84 | LMNA (0.54) | TDP1LMNAKMT2AMEN1THRB | |
| SCHEMBL268773 | 0.83 | TDP1 (0.44) | TDP1LMNAKMT2AMEN1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117641951-A | Perovskite solar cell, preparation method thereof and photovoltaic module | 通威太阳能（成都）有限公司 | 2024-03-01 | — | — | CN | claimed |
| US-8507896-B2 | Compounds having electroluminescent or electron transport properties | MERCK PATENT GMBH (DE) | 2013-08-13 | — | — | US | claimed |
| US-20110006295-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | MERCK PATENT GMBH | 2011-01-13 | — | — | US | claimed |
| EP-2250151-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | Merck Patent GmbH (DE) | 2010-11-17 | — | — | EP | claimed |
| WO-2009112854-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | MERCK PATENT GMBH (DE) | 2009-09-17 | — | — | WO | claimed |
| EP-1501471-B1 | USE OF ALPHA-DIALDEHYDES IN THE PRESENCE OF AN AMMONIUM SALT OF A BRÖNSTED ACID FOR DYEING KERATIN FIBRES | OREAL (FR) | 2006-06-07 | — | — | EP | claimed |
| US-20050273946-A1 | Use of alpha-dialdehydes in the presence of an ammonium salt of a bronsted acid for dyeing keratin fibres | L'OREAL S.A. (FR) | 2005-12-15 | — | — | US | claimed |
| EP-1501471-A1 | USE OF ALPHA-DIALDEHYDES IN THE PRESENCE OF AN AMMONIUM SALT OF A BRÖNSTED ACID FOR DYEING KERATIN FIBRES | L'OREAL (FR) | 2005-02-02 | — | — | EP | claimed |
| US-20040205905-A1 | Dye composition for keratin fibers, comprising at least one compound chosen from ortho- and alpha-dialdehyde compounds and at least one sulphur compound | L'OREAL S.A. (FR) | 2004-10-21 | — | — | US | claimed |
| EP-1430878-A1 | Composition to dye keratinic fibres comprising at least one ortho- or alpha-dialdehyde and at least one sulphurous compound | L'OREAL (FR) | 2004-06-23 | — | — | EP | claimed |
| WO-2003090701-A1 | USE OF α-DIALDEHYDES IN THE PRESENCE OF AN AMMONIUM SALT OF A BRÖNSTED ACID FOR DYEING KERATIN FIBRES | L'OREAL (FR) | 2003-11-06 | — | — | WO | claimed |
| US-6632629-B2 | Microfluidic in-line labeling method of continuous-flow protease inhibition analysis | CALIPER TECHNOLOGIES CORP. | 2003-10-14 | — | — | US | claimed |
| US-20030064425-A1 | Microfluidic in-line labeling method for continuous-flow protease inhibition analysis | CALIPER TECHNOLOGIES CORP. | 2003-04-03 | — | — | US | claimed |
| US-6468761-B2 | Microfluidic in-line labeling method for continuous-flow protease inhibition analysis | CALIPER TECHNOLOGIES, CORP. | 2002-10-22 | — | — | US | claimed |
| US-20020142473-A1 | Fluorescent labeling method and substrate | GENERAL ELECTRIC COMPANY | 2002-10-03 | — | — | US | claimed |
| US-20010026929-A1 | Microfluidic in-line labeling method for continuous-flow protease inhibition analysis | CALIPER TECHNOLOGIES CORP. | 2001-10-04 | — | — | US | claimed |
| US-6126924-A | Light responsive self-tanning products and methods for use | SCALES-MEDEIROS VIRGINIA A (US) | 2000-10-03 | — | — | US | claimed |
| US-5719061-A | Fluorescent detection of hydrazine, monomethylhydrazine, and 1,1-dimethylhydrazine by derivatization with aromatic dicarboxaldehydes | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1998-02-17 | — | — | US | claimed |
| US-4758520-A | Chemiluminescence method for assaying compounds containing primary amino groups using 1-cyano-2-substituted benz(f)- or naphth(f)-isoindole fluorescers | OREAD LABORATORIES, INC. (US) | 1988-07-19 | — | — | US | claimed |
| EP-0242245-A2 | Chemiluminescence method for assaying compounds containing primary amino groups using 1-cyano-2-substituted benz(f)- or naphth(f)isoindole fluorescers | OREAD LABORATORIES, INC. (US) | 1987-10-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110006295-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | NR2E3, NR4A2, NR4A3 | TDP1 3183/4885LMNA 2067/4885KMT2A 1734/4885 |
| US-20050273946-A1 | Use of alpha-dialdehydes in the presence of an ammonium salt of a bronsted acid for dyeing keratin fibres | KRT18, PDIA5, CA6 | TDP1 2752/4885LMNA 947/4885KMT2A 2950/4885 |
| US-20040205905-A1 | Dye composition for keratin fibers, comprising at least one compound chosen from ortho- and alpha-dialdehyde compounds and at least one sulphur compound | KRT18, DSP, DSG1 | TDP1 3631/4885LMNA 2079/4885KMT2A 2010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.